tiprankstipranks
pc:orice

Oricell Therapeutics Holdings Limited

Oricell Therapeutics Holdings Limited is a clinical-stage biotechnology company developing next-generation cell therapies to address unmet needs in oncology and immunology, with a primary focus on CAR-T therapies for solid tumors. The company leverages three proprietary platforms—Ori®Ab for antibody discovery, Ori®Armoring to enhance T-cell persistence, and OnGo (Fast) CMC for rapid, scalable manufacturing—to advance a diversified pipeline of autologous, secreting, and in vivo CAR-T candidates.

Leadership & Board

Currently, no data available

Latest Estimated Valuation

Estimated Valuation
Estimated Valuation
Total Amount Raised$180M
Total Amount Raised$180M
Total Funding Rounds2
Total Funding Rounds2
Latest Funding Amount$110M
Latest Funding Amount$110M
Latest Funding RoundInvestment
Latest Funding RoundInvestment
Post-Money Valuation
Post-Money Valuation

Funding Round

Funding Date
Funding Round
Amount Raised
Post-Money Valuation
Apr 10, 2026
Investment
$110.00M
Jan 13, 2026
Series C
$70.00M

Related News and Analysis